These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 2517622)

  • 1. Experimental and clinical investigation on oxiconazole.
    Wu SX; Shen YN; Yan N; Guo NR; Liu LL; Yang JQ
    Chin Med J (Engl); 1989 Aug; 102(8):644-6. PubMed ID: 2517622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxiconazole nitrate: pharmacology, efficacy, and safety of a new imidazole antifungal agent.
    Jegasothy BV; Pakes GE
    Clin Ther; 1991; 13(1):126-41. PubMed ID: 2029718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Econazole nitrate. In vitro tests and clinical trial].
    Dorn M; Scherwitz C; Lentze I; Plewig G
    MMW Munch Med Wochenschr; 1975 Apr; 117(16):687-92. PubMed ID: 805931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ciclopirox olamine lotion 1%: bioequivalence to ciclopirox olamine cream 1% and clinical efficacy in tinea pedis.
    Aly R; Maibach HI; Bagatell FK; Dittmar W; Hänel H; Falanga V; Leyden JJ; Roth HL; Stoughton RB; Willis I
    Clin Ther; 1989; 11(3):290-303. PubMed ID: 2663159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What defines the quality of patient care in tinea pedis?
    Mistik S; Ferahbas A; Koc AN; Ayangil D; Ozturk A
    J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):158-65. PubMed ID: 16441623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Once daily treatment with terbinafine 1% cream (Lamisil) for one week is effective in the treatment of tinea corporis and cruris. A placebo-controlled study.
    Budimulja U; Bramono K; Urip KS; Basuki S; Widodo G; Rapatz G; Paul C
    Mycoses; 2001; 44(7-8):300-6. PubMed ID: 11714065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical study of itraconazole for the treatment of Tinea cruris, Tinea corporis and Tinea pedis interdigital].
    Zaitz C; Ruiz LR; Drullis EM; Gurfinkel P; Ciarnuto MA
    Rev Inst Med Trop Sao Paulo; 1990; 32(4):299-303. PubMed ID: 1966257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic efficacy of latoconazole in formulations of clinical use on experimental dermatophytosis in guinea pigs.
    Oka H; Niwano Y; Ohmi T; Tanaka T; Uchida M; Yamaguchi H
    Arzneimittelforschung; 1992 Mar; 42(3):345-9. PubMed ID: 1497697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of an antifungal agent used alone with an antifungal used with a topical steroid in inflammatory tinea pedis.
    Elewski BE; Jones T; Zaias N
    Cutis; 1996 Oct; 58(4):305-7. PubMed ID: 8894432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro susceptibility testing of amorolfine in pathogenic fungi isolated from dermatomycosis patients in China.
    Li RY; Wan Z; Wang AP; Shen YN; Lu CM; Li M; Xi LY; Liu WD; Zeng FQ
    Mycoses; 2004 Oct; 47(9-10):402-6. PubMed ID: 15504124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of butenafine in superficial dermatophytoses (tinea pedis, tinea cruris, tinea corporis).
    Saple DG; Amar AK; Ravichandran G; Korde KM; Desai A
    J Indian Med Assoc; 2001 May; 99(5):274-5. PubMed ID: 11676116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental study of the antimycotic effect of clotrimazole in vitro and in vivo when administered locally].
    Plempel M; Bartmann K
    Arzneimittelforschung; 1972 Aug; 22(8):1280-9. PubMed ID: 4678389
    [No Abstract]   [Full Text] [Related]  

  • 13. Oxiconazole nitrate lotion, 1 percent: an effective treatment for tinea pedis.
    Pariser DM; Pariser RJ
    Cutis; 1994 Jul; 54(1):43-4. PubMed ID: 7924451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulconazole nitrate 1.0 percent cream: a comparison with miconazole in the treatment of tinea pedis and tinea cruris/corporis.
    Tanenbaum L; Anderson C; Rosenberg MJ; Howard W; McDaniel W; Neimanis A; Ryan ME; Perez R
    Cutis; 1982 Jul; 30(1):105-7, 115, 118. PubMed ID: 6749440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of tinea corporis or tinea cruris with bifonazole 1% gel: an open, multicentre study.
    Belli L; Galimberti R; Negroni R; Rohwedder R; Castro JM
    Pharmatherapeutica; 1985; 4(2):106-8. PubMed ID: 4059289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of clotrimazole. A broad-spectrum antifungal agent.
    Spiekermann PH; Young MD
    Arch Dermatol; 1976 Mar; 112(3):350-2. PubMed ID: 769697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical antifungal activity of thiabendazole.
    Battistini F; Zaias N; Sierra R; Rebell G
    Arch Dermatol; 1974 May; 109(5):695-9. PubMed ID: 4275184
    [No Abstract]   [Full Text] [Related]  

  • 18. Tolciclate versus miconazole, a double-blind trial in patients with dermatomycosis.
    Cucè LC; Assunção BF; Medawar LG; Salibian A; Groppi W
    J Int Med Res; 1980; 8(2):144-7. PubMed ID: 6989684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, multicenter, double-blind, vehicle-controlled study evaluating the efficacy and safety of luliconazole cream 1% once daily for 7 days in patients aged ≥ 12 years with tinea cruris.
    Jones TM; Jarratt MT; Mendez-Moguel I; Paz N; Grekin SK; Cognata Smith C; Kaur M
    J Drugs Dermatol; 2014 Jan; 13(1):32-8. PubMed ID: 24385117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Miconazole--a new topical antifungal drug.
    Med Lett Drugs Ther; 1974 Nov; 16(24):97-8. PubMed ID: 4431382
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.